Comparative in vitro activity of L-ofloxacin and FK037 to other agents against 10,040 fresh clinical isolates

International Journal of Antimicrobial Agents

Volumn 6, Issue 4, 1996, Pages 201-221

  Cooper, Isabell ^a   Isbell, Deborah J ^b   Kruszynski, Julie A ^a   Peterson, Lance R ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b R W JOHNSON PHARMACEUTICAL RES I   (United States)

Author keywords

FK037; Fresh isolates; In vitro activity; L Ofloxacin; MRSA; MRSE; Staphylococci

Indexed keywords

AMIKACIN; AMPICILLIN; ANTIINFECTIVE AGENT; CEFAZOLIN; CEFOPERAZONE; CEFOSELIS; CEFTAZIDIME; CEFTIZOXIME; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; GENTAMICIN; IMIPENEM; METICILLIN; OFLOXACIN; OXACILLIN; PENICILLIN G; RIFAMPICIN; SULTAMICILLIN; TETRACYCLINE; TOBRAMYCIN; VANCOMYCIN;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIUM ISOLATION; CONTROLLED STUDY; ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS HAEMOLYTICUS; STREPTOCOCCUS PNEUMONIAE;

EID: 0029922044     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/0924-8579(95)00039-9     Document Type: Article

References (16)

1. Emori TG, Gaynes RP. An overview of nosocomial infections, including the role of the Microbiology laboratory. Clin Microbiol Rev 1993;6:428-442.
2. Foleno BD, Lafredo SC, Fu KP. In vitro activity of levofloxacin, ofloxacin and other quinolones against coagulase-negative staphylococci. Chemotherapy 1993;39:120-123.
3. Fu KP, Foleno BD, Lafredo SC, LoCoco JM, Isaacson DM. In vitro and in vivo antibacterial activities of FK037, a novel parenteral broad-spectrum cephalosporin. Antimicrob Agents Chemother 1993;37:301-307.
4. Fu KP, Lafredo SC, Foleno BD, Isaacson DM, Barrett JF. Tobia AJ, Rosenthale ME. In vitro and in vivo antibacterial activities of levofloxacin (L-ofloxacin), an optically active isomer. Antimicrob Agents Chemother 1992;36:860-866.
5. Fujimoto T, Mitsuhashi S. In vitro activity of DR-3355, the S-(-)-isomer of ofloxacin. Chemotherapy 1990;36:268-276.
6. Haley RW, Culver DH, White JW, Morgan WM, Emori TG, Munn VP, Hooton TM. The efficacy of infection surveillance and control programs in preventing nosocomial infections in U.S. hospitals. Am J Epidemiol 1985:121:182-205.
7. Jones RN. Preliminary interpretive susceptibility testing criteria for FK-037 with 30-microgram disks. Antimicrob Agents Chemother 1994;32:1104-1106.
8. Jones RN, Barrett MS, Erwin ME. In-vitro activity of FK-037, a new parenteral cephalosporin. J Antimicrob Chemother 1994;33:137-144.
9. Kato N, Kato H, Tanaka Y, Bando K, Watanabe K, Ueno K. In vitro activity of FK037, a new parenteral cephalosporin, against anaerobic bacteria. Antimicrob Agents Chemother 1993;37:957-961.
10. Mine Y, Wantanabe Y, Sakamoto H, Hatano K, Kuno K, Higashi Y, Kamimura T, Matsumoto Y, Tawara S, Matsumoto F, Kuwahara S. In vitro antibacterial activity of FK037, a novel parenteral broad-spectrum cephalosporin. J Antibiot 1993;46:71-87.
11. Mine Y, Wantanabe Y, Sakamoto H, Hatano K, Kuno K, Kamimura T, Tawara S, Matsumoto Y, Matsumoto F, Kuwahara S. Excellent activity of FK-037, a novel parenteral broad-spectrum cephalosporin, against methicillin-resistant staphylococci. J Antibiot 1993;46:99-119.
12. Mine Y, Wantanabe Y, Sakamoto H, Hatano K, Wakai Y, Kamimura T, Tawara S, Matsumoto S, Matsumoto F, Kuwahara S. In vivo antibacterial activity of FK037, a novel parenteral broadspectrum cephalosporin. J Antibiot 1993;46:88-98.
13. NCCLS Document M7-A3-1993. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically, ed 3. Approved Standard, National Committee for Clinical Laboratory Standards. Villanova, PA.
14. Neu HC, Chin NX, Huang HB. In vitro activity and β-lactamase stability of FK-037, a parenteral cephalosporin. Antimicrob Agents Chemother 1993;37:566-573.
15. Peterson LR, Cooper I, Willard KE, Fasching CE, Sinn LM, Shanholtzer CJ, Gerding DN. Activity of 21 antimicrobial agents including L-Ofloxacin against quinolone sensitive and -resistant, and methicillin-sensitive and -resistant Staphylococcus aureus. Chemotherapy 1994;42:21-25.
16. Washington JA, Jones RN, Gerlach EH, Murray PR, Allen SD, Knapp CC. Multicenter comparison of in vitro activities of FK-037, cefepime, ceftriaxone, ceftazidime, and cefuroxime. Antimicrob Agents Chemother 1993;37:1696-1700.